Gedeon Richter PLC (BUD:RICHTER)

Revenue by Segment

Financials in millions HUF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceuticals - Neuropsychiatry (CNS)	264.70B	242.75B	205.66B	145.90B	-
Pharmaceuticals - General Medicines (GM)	249.53B	250.71B	226.89B	225.92B	-
Pharmaceuticals - Women's Healthcare (WHC)	328.57B	286.22B	255.67B	229.21B	-
Pharmaceuticals - Biotechnology (BIO)	64.16B	54.01B	46.20B	41.19B	-
Pharmaceuticals - Pharma Other	6.99B	11.12B	13.02B	14.13B	-
Other	25.58B	24.98B	70.87B	164.29B	7.15B
Eliminations	-10.58B	-12.24B	-13.16B	-17.88B	-15.79B
Pharmaceuticals	-	-	-	-	505.02B
Wholesale and Retail	-	-	-	-	134.21B
Total	928.96B	857.55B	805.16B	802.76B	630.60B

Revenue by Geography

Financials in millions HUF. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Europe	550.52B	511.36B	500.96B	563.38B	263.44B
APAC	54.71B	48.62B	43.07B	39.08B	-
North America	276.38B	255.34B	221.19B	165.98B	-
Latin America	38.31B	35.53B	31.68B	27.88B	17.60B
Rest of The World	9.05B	6.71B	8.26B	6.44B	31.24B
Hungary	-	-	-	-	44.38B
United States of America	-	-	-	-	122.99B
China	-	-	-	-	15.59B
CIS (Commonwealth of Independent States)	-	-	-	-	135.35B
Total	928.96B	857.55B	805.16B	802.76B	630.60B

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 13, 2026

Data Sources Report a data error